Keeping you up to date on recent developments in oncology, including: NIH drug screening protocol identifies treatment for SCLC; Explanation for DR5 antibody problem surfaces; Location, location, location in avoidance of esophagitis.

Keeping you up to date on recent developments in oncology, including: Popcorn-like gold nanofilms for detection of miRNA in cancer; Myeloid cells differ in primary and recurrent glioblastoma; Premetastatic niche is prepared via leaky gut in colorectal cancer; Brain metastases of breast cancer depend on fatty acid synthesis.

Keeping you up to date on recent developments in oncology, including: NCI team devises method to recruit myeloid cells in pushback against cancer; Algorithm ranks cancer therapies for efficacy; New twist on quantum dots could revolutionize imaging.

Keeping you up to date on recent developments in oncology, including: New technique may enable electrons in cancer radiotherapy; Universal initiates study of cell-free DNA blood test; Concerns linger about cardiovascular risk factors in conjunction with cancer treatment.

Keeping you up to date on recent developments in oncology, including: Rethinking dose fractionation in radiotherapy for prostate cancer; Immune system, treatment, in kidney cancer; Targeting membrane protein starves pancreatic tumors; Olive oil, not just for pasta anymore.

Keeping you up to date on recent developments in oncology, including: USPSTF lowers recommended starting age for lung cancer screening; Suppression of collagen production boosts production of Cxcl5; Immigrants from China face barriers to cancer screening.

Keeping you up to date on recent developments in oncology, including: Imaging studies offer clarity on impact of combo therapy in metastatic breast cancer; Antidiarrheal drug fights AML; Peering past gastrointestinal mucosa to find tumors; Nanosac to the rescue for solid tumor therapy.

Keeping you up to date on recent developments in oncology, including: MR touted as potential screening modality for prostate cancer; Classifying variants of unknown significance; Tumor neoantigens can inhibit immune response; MEK perhaps a useful target in some bladder cancers.

Keeping you up to date on recent developments in oncology, including: CD161 identified as impediment to immune response in diffuse glioma; iPSCs give sneak preview of AML; A role for chloroquine in cancer; Fecal transplant may aid in response to immunotherapy in melanoma.

Keeping you up to date on recent developments in oncology, including: Less fractionation, fewer trips not a problem for some high-risk prostate cancers; PCOS passed on in the epigenes; Algorithm uses ultrasound images for classification.